Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7747 | 1254 | 38.0 | 64% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2418 | 3679 | SPLUNC1//ENDOTOXIN REMOVAL//POLYMYXIN B IMMOBILIZED FIBER |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTILIPID A | Author keyword | 4 | 75% | 0% | 3 |
| 2 | ELEBUTE SCORE | Author keyword | 4 | 75% | 0% | 3 |
| 3 | ANTIBIOTIC INDUCED ENDOTOXIN RELEASE | Author keyword | 3 | 100% | 0% | 3 |
| 4 | IGM ENRICHED IMMUNOGLOBULIN | Author keyword | 3 | 100% | 0% | 3 |
| 5 | ANTI LIPOPOLYSACCHARIDE ANTIBODIES | Author keyword | 3 | 60% | 0% | 3 |
| 6 | HA 1A | Author keyword | 3 | 60% | 0% | 3 |
| 7 | ANTILIPOPOLYSACCHARIDE | Author keyword | 2 | 67% | 0% | 2 |
| 8 | AZD9773 | Author keyword | 2 | 67% | 0% | 2 |
| 9 | EDINBURGH SE SCOTLAND REG TRANSFUS | Address | 2 | 67% | 0% | 2 |
| 10 | ENDOTOXIN CORE ANTIBODIES | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTILIPID A | 4 | 75% | 0% | 3 | Search ANTILIPID+A | Search ANTILIPID+A |
| 2 | ELEBUTE SCORE | 4 | 75% | 0% | 3 | Search ELEBUTE+SCORE | Search ELEBUTE+SCORE |
| 3 | ANTIBIOTIC INDUCED ENDOTOXIN RELEASE | 3 | 100% | 0% | 3 | Search ANTIBIOTIC+INDUCED+ENDOTOXIN+RELEASE | Search ANTIBIOTIC+INDUCED+ENDOTOXIN+RELEASE |
| 4 | IGM ENRICHED IMMUNOGLOBULIN | 3 | 100% | 0% | 3 | Search IGM+ENRICHED+IMMUNOGLOBULIN | Search IGM+ENRICHED+IMMUNOGLOBULIN |
| 5 | ANTI LIPOPOLYSACCHARIDE ANTIBODIES | 3 | 60% | 0% | 3 | Search ANTI+LIPOPOLYSACCHARIDE+ANTIBODIES | Search ANTI+LIPOPOLYSACCHARIDE+ANTIBODIES |
| 6 | HA 1A | 3 | 60% | 0% | 3 | Search HA+1A | Search HA+1A |
| 7 | ANTILIPOPOLYSACCHARIDE | 2 | 67% | 0% | 2 | Search ANTILIPOPOLYSACCHARIDE | Search ANTILIPOPOLYSACCHARIDE |
| 8 | AZD9773 | 2 | 67% | 0% | 2 | Search AZD9773 | Search AZD9773 |
| 9 | ENDOTOXIN CORE ANTIBODIES | 2 | 67% | 0% | 2 | Search ENDOTOXIN+CORE+ANTIBODIES | Search ENDOTOXIN+CORE+ANTIBODIES |
| 10 | ENDOTOXIN ANTIBODIES | 2 | 50% | 0% | 3 | Search ENDOTOXIN+ANTIBODIES | Search ENDOTOXIN+ANTIBODIES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEGATIVE BACTERIAL SEPSIS | 55 | 65% | 4% | 52 |
| 2 | ESCHERICHIA COLI J5 | 36 | 66% | 3% | 33 |
| 3 | GRAM NEGATIVE BACTEREMIA | 33 | 21% | 11% | 138 |
| 4 | ANTIBIOTIC INDUCED RELEASE | 29 | 63% | 2% | 29 |
| 5 | ENDOTOXIN CORE | 19 | 80% | 1% | 12 |
| 6 | ROUGH MUTANTS | 17 | 51% | 2% | 24 |
| 7 | SALMONELLA MINNESOTA | 16 | 33% | 3% | 40 |
| 8 | HA 1A | 16 | 53% | 2% | 21 |
| 9 | GRAM NEGATIVE SEPSIS | 15 | 20% | 5% | 64 |
| 10 | LPS RELEASE | 14 | 100% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Special issue: Sepsis Why have clinical trials in sepsis failed? | 2014 | 21 | 45 | 24% |
| Why immunomodulatory therapies have not worked in sepsis | 1999 | 163 | 89 | 29% |
| Clinical implications of antibiotic-induced endotoxin release in septic shock | 2002 | 64 | 84 | 45% |
| Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock | 2013 | 3 | 78 | 59% |
| Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis | 2006 | 28 | 54 | 37% |
| Anti-endotoxin vaccines Back to the future | 2014 | 4 | 52 | 62% |
| Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review | 2001 | 47 | 107 | 63% |
| Clinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis? | 1999 | 139 | 75 | 25% |
| Animal models of sepsis | 2014 | 11 | 115 | 24% |
| CLINICAL RELEVANCE OF ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE | 1994 | 96 | 66 | 58% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EDINBURGH SE SCOTLAND REG TRANSFUS | 2 | 67% | 0.2% | 2 |
| 2 | HOSP AGATHARIED | 1 | 100% | 0.2% | 2 |
| 3 | OFF MED ADM | 1 | 40% | 0.2% | 2 |
| 4 | CIBE CB06 06 0028 | 1 | 50% | 0.1% | 1 |
| 5 | GREAT LAKES NAVAL TRAINING | 1 | 50% | 0.1% | 1 |
| 6 | HBEREICH VET MED MITTE | 1 | 50% | 0.1% | 1 |
| 7 | INFECTIOL MICROBIOL HYG | 1 | 50% | 0.1% | 1 |
| 8 | INVEST RED ENFERMEDADES PIRATORIAS CIBE | 1 | 50% | 0.1% | 1 |
| 9 | MED SEPT SHOCK PROGRAM | 1 | 50% | 0.1% | 1 |
| 10 | MICROBIAL IMMUN | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000235111 | POLYMYXIN B IMMOBILIZED FIBER//PMX DHP//TORAYMYXIN |
| 2 | 0.0000156962 | CHEM BIOCHEM DISCIPLINE//LIPOPOLYAMINES//IND CHEM ENVIROMENTAL ENGN |
| 3 | 0.0000117921 | SPLUNC1//BACTERICIDAL PERMEABILITY INCREASING PROTEIN//PLUNC |
| 4 | 0.0000103481 | RD BIOSCI//PSEUDOMONAS VACCINE//PNEUMONIA CLIN |
| 5 | 0.0000097128 | APOLIPOPROTEIN B EXPRESSION//ENDOTOXIN NEUTRALIZATION//MOL MECH INFECT |
| 6 | 0.0000095764 | RABBIT PYROGEN TEST//MONOCYTE ACTIVATION TEST//PYROGEN TEST |
| 7 | 0.0000092762 | LIPID A ANALOG//LIPID A//LPS ANTAGONIST |
| 8 | 0.0000091085 | IMMUNOPARALYSIS//ANESTHESIOL MED SURG//CECAL LIGATION AND PUNCTURE |
| 9 | 0.0000085536 | SEPTIC CARDIOMYOPATHY//CARDIONOME//MYOCARDIAL DEPRESSION |
| 10 | 0.0000079273 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |